Covered recipient · General Payments record
MINDY A AUGUSTINE
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2022–2024
$486.70
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $184.78 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Stemline Therapeutics Inc. | $27.64 | 1 |
| Genmab U.S., Inc. | $26.15 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23.06 | 1 |
| Octapharma USA, Inc. | $21.26 | 1 |
| Pharmacosmos Therapeutics Inc. | $19.96 | 1 |
| Acerta Pharma LLC | $19.87 | 1 |
| Karyopharm Therapeutics Inc. | $19.35 | 1 |
| TAIHO ONCOLOGY, INC. | $13.96 | 1 |
| Astellas Pharma US Inc | $13.53 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $13.53 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139488836 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.87 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105583576 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23.06 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118213418 | CMS |
| Genmab U.S., Inc. | $26.15 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126838286 | CMS |
| Karyopharm Therapeutics Inc. | $19.35 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145541024 | CMS |
| Octapharma USA, Inc. | $21.26 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142321050 | CMS |
| Pharmacosmos Therapeutics Inc. | $19.96 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154827545 | CMS |
| Stemline Therapeutics Inc. | $27.64 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142969643 | CMS |
| TAIHO ONCOLOGY, INC. | $13.96 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137944101 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.